ChemicalBook > CAS DataBase List > GIP (HUMAN)

GIP (HUMAN)

Product Name
GIP (HUMAN)
CAS No.
100040-31-1
Chemical Name
GIP (HUMAN)
Synonyms
GIP;GIP (HUMAN);GIP (Total);GIP (active);M.W. 4983.59 C226H338N60O66S;GASTRIC INHIBITORY PEPTIDE HUMAN;GASTRIC INHIBITORY POLYPEPTIDE (HUMAN);YAEGTFISDYSIAMDKIHQQDFVNWLLAQKGKKNDWKHNITQ;Gastric inhibitorypolypeptide (human) (9CI);Gastric inhibitory polypeptide human, ≥95% (HPLC)
CBNumber
CB3381115
Molecular Formula
C226H338N60O66S
Formula Weight
4983.52932
MOL File
100040-31-1.mol
More
Less

GIP (HUMAN) Property

storage temp. 
−20°C
form 
Solid
color 
White to off-white
Water Solubility 
Soluble to 1 mg/ml in water
Sequence
H-Tyr-Ala-Glu-Gly-Thr-Phe-Ile-Ser-Asp-Tyr-Ser-Ile-Ala-Met-Asp-Lys-Ile-His-Gln-Gln-Asp-Phe-Val-Asn-Trp-Leu-Leu-Ala-Gln-Lys-Gly-Lys-Lys-Asn-Asp-Trp-Lys-His-Asn-Ile-Thr-Gln-OH
More
Less

Safety

WGK Germany 
3
More
Less

Hazard and Precautionary Statements (GHS)

More
Less

N-Bromosuccinimide Price

Sigma-Aldrich
Product number
G2269
Product name
Gastric Inhibitory Polypeptide human
Purity
≥95% (HPLC)
Packaging
0.1mg
Price
$404
Updated
2024/03/01
Sigma-Aldrich
Product number
G2269
Product name
Gastric Inhibitory Polypeptide human
Purity
≥95% (HPLC)
Packaging
0.5mg
Price
$1620
Updated
2024/03/01
Sigma-Aldrich
Product number
G2269
Product name
Gastric Inhibitory Polypeptide human
Purity
≥95% (HPLC)
Packaging
.1mg
Price
$358
Updated
2022/05/15
Sigma-Aldrich
Product number
G2269
Product name
Gastric Inhibitory Polypeptide human
Purity
≥95% (HPLC)
Packaging
.5mg
Price
$1440
Updated
2022/05/15
Alfa Aesar
Product number
J66667
Product name
Gastric Inhibitory Peptide, human
Packaging
0.5mg
Price
$135
Updated
2021/12/16
More
Less

GIP (HUMAN) Chemical Properties,Usage,Production

Description

GIP was originally isolated as a gastric inhibitory polypeptide. After the discovery of its glucose-dependent insulinotropic activity, known as the incretin effect, GIP was renamed glucose-dependent insulinotropic peptide.
Gastric inhibitory peptide
Abbreviation: GIP
Additional names: gastric inhibitory polypeptide,gastrointestinal inhibitory peptide, glucose-dependent, insulinotropic peptide

Chemical Properties

Human GIP: Mr 4983.6, theoretical pI 6.92. GIP is soluble in water, but insoluble in ethanol. GIP is inactivated by DPP-4.

History

GIP was originally isolated from the porcine intestinal extract on the basis of its acid inhibitory activity in dogs (gastric inhibitory polypeptide) in the early 1970s, and subsequently renamed glucose-dependent insulinotropic peptide after the finding of its physiologically important role as a potentiator of glucose-stimulated insulin secretion.

Uses

GIP possessing incretin activity enhances glucosestimulated insulin release. GIP agonists are potentially useful for the treatment of diabetes. Moreover, DPP-4 inhibitors are approved for use in diabetes patients because GIP is rapidly deactivated by DPP-4.

Biosynthesis

The expression of GIP is regulated by nutrients. The administration of glucose and lipid into the rat gastrointestinal tract increases GIP mRNA levels. Circulating GIP levels are low in the fasted state and increase within minutes of food ingestion. The postprandial levels of circulating GIP are dependent on meal size. The degree to which nutrients regulate GIP secretion is speciesdependent. Fat is a more potent stimulator than carbohydrates in humans, whereas in the rodent and pig, carbohydrates are more potent than fat. Once released, GIP is rapidly deactivated by DPP-4.

Receptors

Structure and subtype
The receptor of GIP is a seven-transmembrane GPCR that belongs to a subclass of the family B. Both the relatively long extracellular N-terminal domain and the first transmembrane domain are important for ligand binding and receptor activation. The C-terminal cytoplasmic domain of the receptor is important for receptor desensitization and internalization. Like their peptide ligands, the GIP receptor and the GLP-1 receptor exhibit high degrees of amino acid sequence identity, with similar molecular structures and signaling processes. However, GIP does not bind to the GLP-1 receptor and vice versa.
Signal transduction pathway
Ligand binding to the GIP receptor primarily activates adenylyl cyclase and increases intracellular cAMP.6 The activation of the MAP kinase pathway, the phospholipase A2 pathway, and the phosphatidylinositol 3-kinase/protein kinase B pathway have also been reported.
Agonist
[D-Ala2]-GIP is an agonist. Tirzepatide (LY3298176) is a dual agonist of GIP and GLP-1 receptors.
Antagonists
GIP(6–30), ANTGIP (GIP-(7–30)-NH2) (a truncated GIP peptide antagonist), GIP(3–30)NH2 (a truncated GIP peptide antagonist), and [Pro3]-GIP; Exendin(9–39) amide are antagonists.

storage

Store at -20°C

Structure and conformation

Human GIP is a single 42-aa peptide. The structure of vertebrate GIP is well conserved and both the N-terminal and central regions are important for biological activity because truncated forms of GIP, GIP(1–39), and GIP (1–30) show a high degree of biological activity.2 The N-terminal two aa residues are cleaved off by dipeptidyl-peptidase 4 (DPP-4) in the circulation to form GIP(3–42), which has no insulinotropic activity.

GIP (HUMAN) Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

GIP (HUMAN) Suppliers

MedChemexpress LLC
Tel
021-58955995
Fax
609-228-5909
Email
sales@medchemexpress.cn
Country
United States
ProdList
4861
Advantage
58
Alfa Chemistry
Tel
Fax
1-516-927-0118
Email
Info@alfa-chemistry.com
Country
United States
ProdList
24072
Advantage
58
BOC Sciences
Tel
+1-631-485-4226
Fax
1-631-614-7828
Email
inquiry@bocsci.com
Country
United States
ProdList
19553
Advantage
58
TargetMol Chemicals Inc.
Tel
Email
support@targetmol.com
Country
United States
ProdList
38469
Advantage
58
Aladdin Scientific
Tel
+1-+1(833)-552-7181
Email
sales@aladdinsci.com
Country
United States
ProdList
57505
Advantage
58
ApexBio Technology
Tel
--
Fax
--
Email
sales@apexbt.com
Country
United States
ProdList
6251
Advantage
58
Alfa Chemistry
Tel
--
Fax
--
Email
info@Alfa-Chemistry.com
Country
United States
ProdList
6814
Advantage
0
Creative Enzymes
Tel
--
Fax
--
Email
info@creative-enzymes.com
Country
United States
ProdList
6057
Advantage
58
MedChemExpress
Tel
--
Fax
--
Email
sales@medchemexpress.com
Country
United States
ProdList
6398
Advantage
58
Riedel-de Haen AG
Tel
--
Fax
--
Country
United States
ProdList
6773
Advantage
87
3B Scientific Corporation
Tel
--
Fax
--
Email
sales@3bsc.com
Country
United States
ProdList
6718
Advantage
47
LKT Laboratories, Inc.
Tel
--
Fax
--
Email
info@lktlabs.com
Country
United States
ProdList
2164
Advantage
64
GenScript Corporation
Tel
--
Fax
--
Email
info@genscript.com
Country
United States
ProdList
400
Advantage
77
The Peptide Laboratory
Tel
--
Fax
--
Email
info@peptidelab.com
Country
United States
ProdList
224
Advantage
30
Chem-Impex International, Inc.
Tel
--
Fax
--
Country
United States
ProdList
6730
Advantage
64
SynPep Corporation
Tel
--
Fax
--
Email
sales@synpep.com
Country
United States
ProdList
1943
Advantage
51
American Peptide Company
Tel
--
Fax
--
Email
sales@americanpeptide.com
Country
United States
ProdList
1718
Advantage
71
AnaSpec, Inc.
Tel
--
Fax
--
Email
service@anaspec.com
Country
United States
ProdList
4871
Advantage
77
More
Less

View Lastest Price from GIP (HUMAN) manufacturers

Wuhan Senwayer Century Chemical Co.,Ltd
Product
GIP (HUMAN) 100040-31-1
Price
US $0.00/MG
Min. Order
1MG
Purity
98%
Supply Ability
20 TONS
Release date
2023-07-27
Career Henan Chemical Co
Product
GIP (HUMAN) 100040-31-1
Price
US $7.00/KG
Min. Order
1KG
Purity
99%
Supply Ability
100KG
Release date
2020-02-11

100040-31-1, GIP (HUMAN)Related Search:


  • H-TYR-ALA-GLU-GLY-THR-PHE-ILE-SER-ASP-TYR-SER-ILE-ALA-MET-ASP-LYS-ILE-HIS-GLN-GLN-ASP-PHE-VAL-ASN-TRP-LEU-LEU-ALA-GLN-LYS-GLY-LYS-LYS-ASN-ASP-TRP-LYS-HIS-ASN-ILE-THR-GLN-OH
  • GLUCOSE-DEPENDENT INSULINOTROPIC POLYPEPTIDE (HUMAN)
  • GASTRIC INHIBITORY PEPTIDE HUMAN
  • GASTRIC INHIBITORY POLYPEPTIDE (HUMAN)
  • GIP (HUMAN)
  • GIP
  • YAEGTFISDYSIAMDKIHQQDFVNWLLAQKGKKNDWKHNITQ
  • TYR-ALA-GLU-GLY-THR-PHE-ILE-SER-ASP-TYR-SER-ILE-ALA-MET-ASP-LYS-ILE-HIS-GLN-GLN-ASP-PHE-VAL-ASN-TRP-LEU-LEU-ALA-GLN-LYS-GLY-LYS-LYS-ASN-ASP-TRP-LYS-HIS-ASN-ILE-THR-GLN
  • Gastric Inhibitory Polypeptide (huMan) GIP (huMan), Glucose-Dependent Insulinotropic Polypeptide (huMan)
  • GIP (huMan), Glucose-Dependent Insulinotropic Polypeptide (huMan)
  • GIP, Tyr-Ala-Glu-Gly-Thr-Phe-Ile-Ser-Asp-Tyr-Ser-Ile-Ala-Met-Asp-Lys-Ile-His-Gln-Gln-Asp-Phe-Val-Asn-Trp-Leu-Leu-Ala-Gln-Lys-Gly-Lys-Lys-Asn-Asp-Trp-Lys-His-Asn-Ile-Thr-Gln
  • M.W. 4983.59 C226H338N60O66S
  • REF DUPL: H-Tyr-Ala-Glu-Gly-Thr-Phe-Ile-Ser-Asp-Tyr-Ser-Ile-Ala-Met-Asp-Lys-Ile-His-Gln-Gln-Asp-Phe-Val-Asn-Trp-Leu-Leu-Ala-Gln-Lys-Gly-Lys-Lys-Asn-Asp-Trp-Lys-His-Asn-Ile-Thr-Gln-OH
  • Gastric inhibitorypolypeptide (human) (9CI)
  • Gastric Inhibitory Polypeptide huManGastric Inhibitory Polypepti
  • Gastric inhibitory polypeptide human, ≥95% (HPLC)
  • GIP (active)
  • GIP (Total)
  • 100040-31-1
  • C226H338N60O66S
  • Gastrointestinal Products
  • Gastric Inhibitory Polypeptides
  • Peptides
  • Biochemicals and Reagents
  • BioChemical
  • Amino Acids and Peptides
  • peptide
  • Glucagon receptor and related